Cancer incidence in Gipuzkoa, Spain (1998-2002), and time trends from 1986

Gaceta Sanitaria

Volumn 22, Issue 3, 2008, Pages 188-196

  Larrañaga, Nerea ^a,b,e   Sarasqueta, Cristina ^b,c   Michelena, M Jesús ^d  

^a Departamento de Sanidad   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d Instituto Oncológico   (Spain)

^e Laboratorio Normativo de Salud Pública   (Spain)

Author keywords

Cancer; Incidence; Neoplasm; Trends

Indexed keywords

EID: 45849128965     PISSN: 02139111     EISSN: 15781283     Source Type: Journal    
DOI: 10.1157/13123962     Document Type: Article

References (42)

1. a ed. Vitoria-Gasteiz: Servicio central de Publicaciones del Gobierno Vasco; 2002.
2. Lagiou P, Adammi HO. Burden of cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. New York: Oxford University Press; 2002. p. 3-28.
3. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeeet RG. Registros de cáncer. Principios y métodos. Lyon: IARC; 1995. Publicaciones científicas no. 95.
4. Parkin DM, Chen VW, Ferlay J, Galceran J, Storm HH, Whelan SL. Comparabilidad y control de calidad en los registros de cáncer. Lyon: IARC; 1995. Informe Técnico no. 19.
5. Izarzugaza JM, Juan D, Pons C, Ranea JA, Valencia A, Pazos F. TSEMA: interactive prediction of protein pairings between interacting families. Nucl Acids Res. 2006;34:315W-9W.
6. Izarzugaza MI, Steliarova-Foucher E, Martos MC, Zivkovic S. Non-Hodgkin's lymphoma incidence and survival in European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2050-63.
7. Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, et al. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control. 2003;14:791-803.
8. Stiller CA, Desandes E, Danon SE, Izarzugaza I, Ratiu A, Vassileva-Valerianova Z, et al. Cancer incidence and survival in European adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2006-18.
9. Verdecchia A, Micheli A, Colonna M, Moreno V, Izarzugaza MI, Paci E. A comparative analysis of cancer prevalence in cancer registry areas of France, Italy and Spain. Ann Oncol. 2002;13:1128-39.
10. Ferlay J. IARC-Check, de IARC-tolls v2.10 [computer program]. Lyon: IARC; 1999.
11. a ed. Ginebra: OMS; 1995.
12. Frome EI, Checkoway H. Use of Poisson regression models in estimating incidence rates and ratios. Am J Epidemiol. 1985;151:309-23.
13. Kim HJ, Fay MP, Feur EJ, Midthune DN. Permutation tests for Joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51 [correction: 2001;20:655].
14. SAS® 9.1.3 [computer program]. Cary: SAS Institute Inc.; 2004.
15. Joinpoint Regression Program, Version 3.0. April 2005 [computer program]. Statistical Research and Applications Branch, National Cancer Institute; 2005.
16. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell JE. Cancer incidence in five continents. Volume VI. Lyon: IARC; 1992. IARC Scientific publications no. 120.
17. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young L. Cancer incidence in five continents. Volume VII. Lyon: IARC; 1997. IARC Scientific publications no. 143.
18. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Volume VIII. Lyon: IARC; 2002. IARC Scientific publications no. 155.
19. Ardanaz E, Moreno C. Registro de cáncer de Navarra. Incidencia y mortalidad por cáncer en Navarra, 1993-1997. Tendencias en los últimos 25 años. Anales Sis San Navarra. 2001;24:339-62.
20. Moreno V, González JR, Soler M, Bosch FX, Kogevinas M, Borrás JM, et al. Estimación de la incidencia de cáncer en España: período 1993-1996. Gac Sanit. 2001;15:380-8.
21. Izquierdo A, González JR, Moreno V, Galcerán J, Marcos-Gragera R, Cleries R, et al. Incidencia del cáncer de mama en Cataluña: análisis de la tendencia. Med Clin (Barc). 2006;126:286-9.
22. Maskarinec G, Zhang Y, Takata Y, Pagano I, Shumay DM, Goodman MT, et al. Trends of breast cancer incidence and risk factor prevalence over 25 years. Breast Cancer Res Treat. 2006;98:45-55.
23. Holford TR, Cronin KA, Mariotto AB, Feuer EJ. Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr. 2006;36:19-25.
24. Quaglia A, Parodi S, Grosclaude P, Martínez-García C, Coebergh JW, Vercelli M. Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe. An analysis of differential trends in incidence and mortality in France, Italy and Spain. Eur J Cancer. 2003;39:654-65.
25. AIRT working group. Italian cancer figures. Report 2006 (I). Incidence, mortality and estimates. Epidemiol Prev. 2006;30 Suppl 2:8-30.
26. Ward EM, Thun MJ, Hannan LM, Jemal A. Interpreting cancer trends. Ann NY Acad Sci. 2006;1076:29-53.
27. Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12:20-37.
28. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in cancer incidence and mortality. Lyon: 1993. IARC Scientific publicacions. no. 121.
29. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer. 2003;41:245-58.
30. Fernández E, Schiaffino A, Borras JM, Shafey O, Villalbi JR, La VC. Prevalence of cigarette smoking by birth cohort among males and females in Spain, 1910-1990. Eur J Cancer Prev. 2003;12:57-62.
31. Shafey O, Fernández E, Thun M, Schiaffino A, Dolwick S, Cokkinides V. Cigarette advertising and female smoking prevalence in Spain, 1982-1997: case studies in International Tobacco Surveillance. Cancer. 2004;100:1744-9.
32. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer. 2003;41:245-58.
33. Stang A, Valiukeviciene S, Aleknaviciene B, Kurtinaitis J. Time trends of incidence, mortality, and relative survival of invasive skin melanoma in Lithuania. Eur J Cancer. 2006;42:660-7.
34. Stang A, Pukkala E, Sankila R, Soderman B, Hakulinen T. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int J Cancer. 2006;119:380-4.
35. Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Br J Cancer. 2006;95:91-5.
36. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer. 2003;107:119-26.
37. De Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer. 2004;40:2355-66.
38. Trimboli P, Ulisse S, Graziano FM, Marzullo A, Ruggieri M, Calvanese A, et al. Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years. Thyroid. 2006;16:1151-5.
39. Lundgren CI, Hall P, Ekbom A, Frisell J, Zedenius J, Dickman PW. Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer. 2003;106:569-73.
40. Ward EM, Thun MJ, Hannan LM, Jemal A. Interpreting cancer trends. Ann NY Acad Sci. 2006;1076:29-53.
41. Cayuela A, Rodríguez-Domínguez S, López-Campos JL, Vigil E. Age-period-cohort analysis of lung cancer mortality rates in Andalusia, 1975-2004. Lung Cancer. 2007;57:261-5.
42. Chirpaz E, Colonna M, Menegoz F, Grosclaude P, Schaffer P, Arveux P, et al. Incidence and mortality trends for prostate cancer in 5 French areas from 1982 to 1996. Int J Cancer. 2002;97:372-6.